Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amber Korn"'
Autor:
Amber Korn, Suat Simsek, Mitchell D. Fiet, Ingeborg S.E. Waas, Hans W.M. Niessen, Paul A.J. Krijnen
Publikováno v:
Journal of Molecular and Cellular Cardiology Plus, Vol 9, Iss , Pp 100083- (2024)
Aims: Diabetes mellitus (DM) induces increased inflammation of atherosclerotic plaques, resulting in elevated plaque instability. Mesenchymal stem cell (MSC) therapy was shown to decrease plaque size and increase stability in non-DM animal models. We
Externí odkaz:
https://doaj.org/article/b1d59157f3b243be9892a8ff0c6d204f
Autor:
Suat Simsek, Casper G Schalkwijk, Hans W M Niessen, Amber Korn, Umit Baylan, Paul A J Krijnen
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/23625a756bc64b768f444e5b9c53d600
Autor:
Laura Louzao-Martinez, Christian G.M. van Dijk, Yan Juan Xu, Amber Korn, Nicolaas J. Bekker, Romi Brouwhuis, Maria Novella Nicese, Jeroen A.A. Demmers, Marie-José T.H. Goumans, Rosalinde Masereeuw, Dirk J. Duncker, Marianne C. Verhaar, Caroline Cheng
Publikováno v:
Matrix Biology Plus, Vol 4, Iss , Pp - (2019)
Cell-based approaches using tissue engineering and regenerative medicine to replace damaged renal tissue with 3D constructs is a promising emerging therapy for kidney disease. Besides living cells, a template provided by a scaffold based on biomateri
Externí odkaz:
https://doaj.org/article/d49840d1cd9f4f2b99a9d8ffdea82076
Autor:
Umit Baylan, Amber Korn, Reindert W. Emmens, Casper G. Schalkwijk, Hans W. M. Niessen, Paul A. J. Krijnen, Suat Simsek
Publikováno v:
Baylan, U, Korn, A, Emmens, R W, Schalkwijk, C G, Niessen, H W M, Krijnen, P A J & Simsek, S 2022, ' Liraglutide treatment attenuates inflammation markers in the cardiac, cerebral and renal microvasculature in streptozotocin-induced diabetic rats ', European Journal of Clinical Investigation, vol. 52, no. 9, e13807 . https://doi.org/10.1111/eci.13807
European Journal of Clinical Investigation, 52(9):13807. Wiley
European Journal of Clinical Investigation, 52(9):e13807
European Journal of Clinical Investigation, 52(9):13807. Wiley
European Journal of Clinical Investigation, 52(9):e13807
BACKGROUND: Diabetes mellitus (DM) induces cardiac and cerebral microvascular dysfunction via increased glycation, oxidative stress and endothelial activation. Liraglutide, a glucagon-like peptide-1 analogue, inhibited NOX2 and adhesion molecules in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970555c5a004c71239c58e419e83e198
https://research.vumc.nl/en/publications/eb202d6a-e281-47dc-bd72-d1c9050941d8
https://research.vumc.nl/en/publications/eb202d6a-e281-47dc-bd72-d1c9050941d8
Publikováno v:
Open Heart, 8(2):e001842. BMJ Publishing Group
Korn, A, Baylan, U, Simsek, S, Schalkwijk, C G, Niessen, H W M & Krijnen, P A J 2021, ' Myocardial infarction coincides with increased NOX2 and Nε-(carboxymethyl) lysine expression in the cerebral microvasculature ', Open Heart, vol. 8, no. 2, 001842 . https://doi.org/10.1136/openhrt-2021-001842, https://doi.org/10.1136/openhrt-2021-001842
Open Heart, Vol 8, Iss 2 (2021)
Open Heart, 8(2):001842. BMJ Publishing Group
Open Heart
Korn, A, Baylan, U, Simsek, S, Schalkwijk, C G, Niessen, H W M & Krijnen, P A J 2021, ' Myocardial infarction coincides with increased NOX2 and Nε-(carboxymethyl) lysine expression in the cerebral microvasculature ', Open Heart, vol. 8, no. 2, 001842 . https://doi.org/10.1136/openhrt-2021-001842, https://doi.org/10.1136/openhrt-2021-001842
Open Heart, Vol 8, Iss 2 (2021)
Open Heart, 8(2):001842. BMJ Publishing Group
Open Heart
BackgroundMyocardial infarction (MI) is associated with mental health disorders, in which neuroinflammation and cerebral microvascular dysfunction may play a role. Previously, we have shown that the proinflammatory factors Nε-(carboxymethyl)lysine (
Autor:
Amber Korn, Laurens F. Reeskamp, Lars E. Larsen, Adriaan G. Holleboom, Mikhaila A Smith, Deepti Abbey, Nicholas J. Hand
Publikováno v:
Atherosclerosis. 303
Dyslipidemias are strongly linked to the development of atherosclerotic cardiovascular disease. Most dyslipidemias find their origin in the liver. In recent years, the differentiation of induced pluripotent stem cells (iPSCs) into hepatocyte-like cel